Top Buy
| Security ▼ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Omeros Corp. | 2 | 4 | 0 | 0 | €3.42 | - | - |
| Ocular Therapeutix Inc. | 7 | 5 | 0 | 1 | €5.73 | €11.40 | 98.980% |
| Novo Nordisk A/S ADR | 17 | 1 | 2 | 0 | €114.50 | €130.00 | 13.537% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
| Novartis AG ADR | 1 | 0 | 0 | 0 | €90.40 | - | - |
| Neurocrine Bioscience | 27 | 0 | 7 | 0 | €130.70 | €140.34 | 7.376% |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | €1.46 | €3.70 | 152.732% |
| Natural Alternat. | 17 | 1 | 0 | 0 | €5.75 | - | - |
| Myriad Genetics | 5 | 2 | 0 | 0 | €18.10 | €23.22 | 28.273% |
| Motus GI Holdings Inc. | 2 | 0 | 0 | 0 | €0.43 | €2.33 | 443.991% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €66.75 | €65.00 | -2.622% |
| Molina Healthcare | 12 | 1 | 2 | 0 | €315.60 | €366.73 | 16.200% |
| Merit Medical Systems | 16 | 0 | 5 | 0 | €70.50 | €86.90 | 23.258% |
| Merck & Co. Inc. | 28 | 1 | 3 | 0 | €118.60 | €124.92 | 5.331% |
| Medtronic plc | 10 | 1 | 0 | 0 | €75.89 | €94.38 | 24.365% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €365.20 | €421.61 | 15.445% |
| Maternus-Kliniken AG | 1 | 0 | 0 | 0 | €1.71 | €1.65 | -3.509% |
| Masimo Corp. | 7 | 1 | 2 | 0 | €127.05 | €147.62 | 16.187% |
| MannKind Corp. | 7 | 0 | 0 | 0 | €4.08 | €6.42 | 57.257% |
| MacroGenics Inc. | 11 | 0 | 3 | 0 | €14.20 | €20.00 | 40.845% |
| M1 Kliniken AG | 2 | 0 | 0 | 0 | €15.75 | - | - |
| LivaNova plc | 9 | 0 | 3 | 0 | €57.00 | €66.59 | 16.829% |
| Lisata Therapeutics Inc. | 1 | 0 | 0 | 0 | €2.42 | €4.00 | 65.289% |
| Lightpath Techs A | 3 | 0 | 0 | 0 | €1.29 | €2.78 | 115.783% |
| Lexicon Pharmaceuticals Inc. | 2 | 0 | 1 | 0 | €1.61 | €5.34 | 231.017% |